YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (1558.HK)

12.660 -0.340 (-2.62%) At close: 04:08PM HKT

YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

No. 38, Binjiang Road
Yidu
Yichang
China

https://www.hec-changjiang.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 4,618

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Juncai Jiang	GM & Executive Director	1.38M	N/A	1982
Mr. Qiang Zhang	CFO & Head of Finance Department	518.54k	N/A	1977
Mr. Yangui Chen	Head of the Sales Department	1.11M	N/A	1981
Mr. Danjin Wang	Deputy GM & Executive Director	989.84k	N/A	1970
Mr. Shuang Li	Deputy GM & Executive Director	861.39k	N/A	1981
Mr. Qiyun Peng	Joint Company Secretary	399.73k	N/A	1991
Mr. Shengchao Wang	Chief of Quality Division & Employee Representative Supervisor	N/A	N/A	1982
Mr. Hao Chen	Executive Director	N/A	N/A	1975
Mr. Wai Chiu Wong FCS	Joint Company Secretary	N/A	N/A	1956

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, sells, and markets pharmaceutical products in the therapeutic areas of anti-infection, endocrine and metabolic, and other diseases in the People's Republic of China. It manufactures and sells active pharmaceutical ingredients; researches and develops pharmaceutical products, and medical devices and drugs, as well as biotechnology; and provides marketing and medical consulting services. The company sells its products to hospitals and medical institutions through a network of distributors. The company's products are Kewei, Oumeining, Xinhaining, Ertongshu, and Xining. It has a strategic cooperation framework agreement with Jointown Pharmaceutical Group Co., Ltd., as well as strategic cooperative partnership with China National Accord Medicines Corporation Ltd. The company was formerly known as Yichang Changjiang Pharmaceutical Company Limited and changed its name to YiChang HEC ChangJiang Pharmaceutical Co., Ltd. in May 2015. The company was incorporated in 2001 and is based in Yichang, China. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. operates as a subsidiary of Sunshine Lake Pharma Co., Ltd.

Corporate governance

YiChang HEC ChangJiang Pharmaceutical Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.